Anthem Biosciences
Bengaluru, India
Program data pending ClinicalTrials.gov matching
78.7
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (9)
○ EMA GMP
○ MHRA GMP
Quick Facts: Anthem Biosciences
- Signal Score
- 78.7/100
- Quality Compliance
- 100.0/100
- Headquarters
- Bengaluru, India
- Modalities
- Small Molecule API, Biologics, Peptide API, Oligonucleotide, ADC, Fermentation (Microbial), HPAPI, Biosimilars, Drug Discovery / Medicinal Chemistry
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Anthem Biosciences
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
FDA Inspections1 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-01-24)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, Biologics, Peptide API, Oligonucleotide, ADC, Fermentation (Microbial), HPAPI, Biosimilars, Drug Discovery / Medicinal Chemistry
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (9 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (9 modalities)
Anthem Biosciences FDA Inspection History
2025-01
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-01-24 | Bengaluru | Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Aug 22, 2026
Recent News 9 articles
Divi’s, Syngene & Laurus: 6 stocks JPMorgan says will lead India’s $15.4 billion CRDMO boom - financialexpress.com
Anthem Biosciences IPO GMP surges as Rs 3,395-crore issue subscribed 64 times on Day 3 - Moneycontrol.com
Pharma stocks that could deliver up to 167% return: Macquarie, Jefferies, JP Morgan top picks - zeebiz.com
Indian CDMO Anthem Biosciences files for $397M IPO amid expansion efforts - Fierce Pharma
Anthem Biosciences IPO: A solid CDMO story, but don’t expect fireworks - Moneycontrol.com
IPO-bound Anthem Bio says cost arbitrage drove expansion, proposing China alternative for global pharma - Moneycontrol.com
CDMOs gear up for peptide boom amid rising demand for weight-loss drugs - Business Standard
Pharma Stocks Rally After Earnings: Where Is The Value Across CDMO And Healthcare? - Business Today
Indian contract drug makers timed their IPOs right. But is the business worth the premium? - livemint.com
Frequently Asked Questions About Anthem Biosciences
How many FDA inspections does Anthem Biosciences have on record?
CDMO Signal tracks 1 FDA inspection for Anthem Biosciences, sourced from the FDA inspection database. See the full inspection history above.
Has Anthem Biosciences received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Anthem Biosciences.
What is Anthem Biosciences's CDMO Signal Score?
Anthem Biosciences has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating Anthem Biosciences for a manufacturing program?
Use the free AI matchmaker to compare Anthem Biosciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Dr. Reddy's Laboratories
Hyderabad, India
Small Molecule API, Generics, Biosimilars, Biologics (Drug Substance & Drug Product), Oligonucleotides, Steroids / Corticosteroids, Oncology / HPAPI, Sterile Injectables / Fill-Finish, Peptide API
Abzena
San Diego, CA; Bristol, PA; Cambridge, UK
Signal Score: 64.0
ADC, AOC, RDC, PDC, DAC, Fusion Proteins, Bispecifics, bsAbs, Multispecifics, msAbs, Bioconjugates, Biologics, mAb, Monoclonal Antibody, Antibodies, Cytokines, HPAPI, Bioconjugation
Veranova
Devens, MA
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
EUROAPI
Paris, France
Small Molecule API, Microbial Fermentation API, Oligonucleotide, Peptide, HPAPI